157 related articles for article (PubMed ID: 35947307)
1. Downregulation of miR-20b-5p Contributes to the Progression of Liver Fibrosis via the STAT3 Signaling Pathway In Vivo and In Vitro.
Lv L; Wang D; Yin J; Yang T; Huang B; Cao Y; Lu J
Dig Dis Sci; 2023 Feb; 68(2):487-496. PubMed ID: 35947307
[TBL] [Abstract][Full Text] [Related]
2. miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression.
Qiu J; Wu S; Wang P; Zhou Y; Wang Z; Sun Y; Jiang C
Hepatol Int; 2023 Apr; 17(2):463-475. PubMed ID: 36001230
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin promotes collagen I synthesis in hepatic stellate cells by miRNA-129-5p inhibition.
Chen Y; Ou Y; Dong J; Yang G; Zeng Z; Liu Y; Liu B; Li W; He X; Lan T
Exp Cell Res; 2018 Jan; 362(2):343-348. PubMed ID: 29196165
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of miR-188-5p alleviates hepatic fibrosis by significantly reducing the activation and proliferation of HSCs through PTEN/PI3K/AKT pathway.
Riaz F; Chen Q; Lu K; Osoro EK; Wu L; Feng L; Zhao R; Yang L; Zhou Y; He Y; Zhu L; Du X; Sadiq M; Yang X; Li D
J Cell Mol Med; 2021 Apr; 25(8):4073-4087. PubMed ID: 33689215
[TBL] [Abstract][Full Text] [Related]
5. miR-140-5p attenuates hepatic fibrosis by directly targeting TGFβR1.
Pan W; Wang Y; Zhao C
Scand J Gastroenterol; 2023; 58(11):1335-1343. PubMed ID: 37313731
[TBL] [Abstract][Full Text] [Related]
6. miR-345-5p curbs hepatic stellate cell activation and liver fibrosis progression by suppressing hypoxia-inducible factor-1alpha expression.
Wang P; Fang Y; Qiu J; Zhou Y; Wang Z; Jiang C
Toxicol Lett; 2022 Nov; 370():42-52. PubMed ID: 36126797
[TBL] [Abstract][Full Text] [Related]
7. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.
Yu F; Chen B; Fan X; Li G; Dong P; Zheng J
Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy.
Chen J; Yu Y; Li S; Liu Y; Zhou S; Cao S; Yin J; Li G
J Cell Mol Med; 2017 Dec; 21(12):3679-3692. PubMed ID: 28766848
[TBL] [Abstract][Full Text] [Related]
9. Anti-Liver Fibrosis Role of miRNA-96-5p via Targeting FN1 and Inhibiting ECM-Receptor Interaction Pathway.
Zhang Y; Gu T; Xu S; Wang J; Zhu X
Appl Biochem Biotechnol; 2023 Nov; 195(11):6840-6855. PubMed ID: 36943602
[TBL] [Abstract][Full Text] [Related]
10. MiR-146a-5p suppresses activation and proliferation of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis through directly targeting Wnt1 and Wnt5a.
Du J; Niu X; Wang Y; Kong L; Wang R; Zhang Y; Zhao S; Nan Y
Sci Rep; 2015 Nov; 5():16163. PubMed ID: 26537990
[TBL] [Abstract][Full Text] [Related]
11. Extracellular vesicles-derived miR-150-5p secreted by adipose-derived mesenchymal stem cells inhibits CXCL1 expression to attenuate hepatic fibrosis.
Du Z; Wu T; Liu L; Luo B; Wei C
J Cell Mol Med; 2021 Jan; 25(2):701-715. PubMed ID: 33342075
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-194 inactivates hepatic stellate cells and alleviates liver fibrosis by inhibiting AKT2.
Wu JC; Chen R; Luo X; Li ZH; Luo SZ; Xu MY
World J Gastroenterol; 2019 Aug; 25(31):4468-4480. PubMed ID: 31496625
[TBL] [Abstract][Full Text] [Related]
13. MiR-9a-5p regulates proliferation and migration of hepatic stellate cells under pressure through inhibition of Sirt1.
Qi F; Hu JF; Liu BH; Wu CQ; Yu HY; Yao DK; Zhu L
World J Gastroenterol; 2015 Sep; 21(34):9900-15. PubMed ID: 26379395
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells improve liver fibrosis and protect hepatocytes by promoting microRNA-148a-5p-mediated inhibition of Notch signaling pathway.
Zhou Q; Rong C; Gu T; Li H; Wu L; Zhuansun X; Zhao X; Xiao Z; Kuang Y; Xu S; Wang S
Stem Cell Res Ther; 2022 Jul; 13(1):354. PubMed ID: 35883205
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-9 limits hepatic fibrosis by suppressing the activation and proliferation of hepatic stellate cells by directly targeting MRP1/ABCC1.
Sun J; Zhang H; Li L; Yu L; Fu L
Oncol Rep; 2017 Mar; 37(3):1698-1706. PubMed ID: 28098912
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of Idelalisib on carbon tetrachloride-induced liver fibrosis via microRNA-124-3P/phosphatidylinositol-3-hydroxykinase signalling pathway.
Li X; Li H; Zhang S; Zhang R; Li J; Wei Y; Yang C; Zhang F; Zhou H
J Cell Mol Med; 2021 Dec; 25(24):11185-11197. PubMed ID: 34747105
[TBL] [Abstract][Full Text] [Related]
17. SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis.
Shen Y; Cheng L; Xu M; Wang W; Wan Z; Xiong H; Guo W; Cai M; Xu F
Metabolism; 2023 Sep; 146():155657. PubMed ID: 37422021
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-20b-5p inhibits platelet-derived growth factor-induced proliferation of human fetal airway smooth muscle cells by targeting signal transducer and activator of transcription 3.
Tang J; Luo L
Biomed Pharmacother; 2018 Jun; 102():34-40. PubMed ID: 29549727
[TBL] [Abstract][Full Text] [Related]
19. The mouse Anxa6/miR-9-5p/Anxa2 axis modulates TGF-β1-induced mouse hepatic stellate cell (mHSC) activation and CCl
Liao J; Zhang Z; Yuan Q; Luo L; Hu X
Toxicol Lett; 2022 Jun; 362():38-49. PubMed ID: 35483553
[TBL] [Abstract][Full Text] [Related]
20. Promotion of hepatic stellate cell activation and liver fibrosis by microRNA-33a-5p through targeting the Dickkopf-1-mediated wingless-related integration site/beta-catenin pathway.
Liu H; Zhang S; Li Z; Zheng Z; Shi W; Hu M; Liu F
J Physiol Pharmacol; 2023 Aug; 74(4):. PubMed ID: 37865960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
